ASCO
3 stories
-
healthGlobal Cancer Care Faces 100 Million Worker Shortfall by 2050
A Lancet study projects a shortage of nearly 100 million cancer workers by 2050, with Africa and Asia hit hardest.
-
healthUltra-Low-Dose Immunotherapy Found to Extend Survival in Head and Neck Cancer
Phase III trial shows TMC-I regimen significantly improves survival over standard chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma.
-
healthNew Pancreatic Cancer Pill Shows Promise, 90% of Patients Respond in Early Trial
An experimental daily pill, daraxonrasib, shows a 90% disease control rate in advanced pancreatic cancer patients during early-stage clinical trials.